Trials / Completed
CompletedNCT06902493
Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury
Impact of Prior Sodium-Glucose Co-Transporter 2 Inhibitor Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 664 (actual)
- Sponsor
- University of Jazan · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The primary objective of this study is to investigate whether using SGLT2i may be associated with decreased incidence of sepsis-induced AKI or not.
Detailed description
The primary objective of this study is to investigate whether using SGLT2i may be associated with decreased incidence of sepsis-induced AKI or not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2025-03-30
- Last updated
- 2025-03-30
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT06902493. Inclusion in this directory is not an endorsement.